1,442
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effect of innate and adaptive immune mechanisms on treatment regimens in an AIDS-related Kaposi's Sarcoma model

, &
Pages 213-249 | Received 27 Aug 2020, Accepted 16 Mar 2021, Published online: 12 Apr 2021

References

  • J.P. Allain and R. Goodrich, Pathogen reduction of whole blood: Utility and feasibility, Transfus. Med. 27 (2017), pp. 320–326.
  • M. Arnedo-Valero, F. García, C. Gil, T. Guila, E. Fumero, P. Castro, J.L. Blanco, J.M. Miró, T. Pumarola, and J.M. Gatell, Risk of selecting de novo drug-Resistance mutations during structured treatment interruptions in patients with chronic HIV infection, Clin. Infect. Dis. 41(6) (2005), pp. 883–890.
  • M.T. Baldridge, K.Y. King, and M.A. Goodell, Inflammatory signals regulate hematopoietic stem cells, Trends Immunol. 32(2) (2011), pp. 57–65.
  • S. Baral, R. Antia, and N.M. Dixit, A Dynamical Motif Comprising the Interactions Between Antigens and CD8 T Cells May Underlie the Outcomes of Viral Infections, Scrpps Research Institute, La Jolla, CA, 2019.
  • S.D. Bella, A. Taddeo, M.L. Calabrò, L. Brambilla, M. Bellinvia, E. Bergamo, M. Clerici, and M.L. Villa, Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's Sarcoma-associated herpesvirus, PLoS ONE 3 (2008), p. e1520.
  • S.D. Bella, A. Taddeo, E. Colombo, L. Brambilla, M. Bellinvia, F. Pregliasco, M. Cappelletti, M.L. Calabrò, and M.L. Villa, Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment, PLoS ONE 5 (2010), p. e15029.
  • C. Boshoff and R. Weiss, AIDS-related malignancies, Nat. Rev. Cancer 2 (2002), pp. 373–382.
  • D.M. Campbell, G. Rappocciolo, F.J. Jenkins, and C.R. Rinaldo, Dendritic cells: Key players in human herpesvirus 8 infection and pathogenesis, Front. Microbiol. 5 (2014), p. 452.
  • C. Castillo-Chavez, S. Blower, P. van den Driessche, D. Kirschner, and A.-A. Yakubu (eds.), On the computation of R0 and its role on global stability, in Mathematical Approaches for Emerging and Reemerging Infectious Diseases: An Introduction (Minneapolis, MN, 1999), IMA Math. Appl., Vol. 125, Springer, New York, 2002, pp. 229–250
  • M.P. Escalon and F.B. Hagemeister, AIDS-related malignancies, in The MD Anderson Manual of Medical Oncology, H.M. Kantarjian, R.A. Wolff, and C.A. Koller, eds., McGraw-Hill, 2006, pp. 903–910
  • V. Fiorelli, R. Gendelman, M.C. Sirianni, H.K. Chang, S. Colombini, P.D. Markham, P. Monini, J. Sonnabend, A. Pintus, R.C. Gallo, and B. Ensoli, Gamma-Interferon produced by CD8+ T-cells infiltrating Kaposi's Sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 tat protein: An immune response to human herpesvirus-8 infection? Blood91(3) (1998), pp. 956–967.
  • W.H. Fleming and R.W. Rishel, Deterministic and Stochastic Optimal Control, Springer-Verlag, New York, 1975.
  • K.E. Foreman, Kaposi's Sarcoma: The role of HHV8 and HIV1 in pathogenesis, Expert Rev. Mol. Med. 3(9) (2001), pp. 1–17.
  • K.E. Foreman, J. Friborg Jr., W.-P. Kong, C. Woffendin, P.J. Polverini, B.J. Nickoloff, and G.J. Nabel, Propagation of a human herpesvirus from AIDS-associated Kaposis Sarcoma, N. Engl. J. Med. 336(3) (1997), pp. 163–171.
  • S. Gramolelli and T.F. Schulz, The role of Kaposi Sarcoma–associated herpesvirus in the pathogenesis of Kaposi Sarcoma, J. Pathol. 235(2) (2015), pp. 368–380.
  • M.M. Hadjiandreou, R. Conejeros, and D.I. Wilson, Long-term HIV dynamics subject to continuous therapy and structured treatment interruptions, Chem. Eng. Sci. 64(7) (2009), pp. 1600–1617.
  • L. Kestens, M. Melbye, R.J. Biggar, W.J. Stevens, P. Piot, A. De Muynck, H. Taelman, M. De Feyter, L.Paluku, and P.L. Gigase, Endemic African Kaposi's Sarcoma is not associated with immunodeficiency, Int. J. Cancer 36(1) (1985), pp. 29–34.
  • D. Kirschner, Using mathematics to understand HIV immune dynamics, Not. AMS 43(2) (1996), pp. 191–202.
  • A.G. Marcelin, I. Gorin, P. Morand, Z. Ait-Arkoub, J. Deleuze, J.P. Morini, V. Calvez, and N. Dupin, Quantification of Kaposi's Sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's Sarcoma, AIDS Res. Human Retrov. 20(7) (2004), pp. 704–708.
  • J.N. Martin, D.E. Ganem, D.H. Osmond, K.A. Page-Shafer, D. Macrae, and D.H. Kedes, Sexual transmission and the natural history of human herpesvirus 8 infection, N. Engl. J. Med. 338(14) (1998), pp. 948–954.
  • J. McCullough, H.J. Alter, and P.M. Ness, Interpretation of pathogen load in relationship to infectivity and pathogen reduction efficacy, Transfusion 59(3) (2019), pp. 1132–1146.
  • P. Monini, S. Colombini, M. Stürzl, D. Goletti, A. Cafaro, C. Sgadari, S. Buttò, M. Franco, P. Leone, S. Fais, P. Leone, G. Melucci-Vigo, C. Chiozzini, F. Carlini, G. Ascherl, E. Cornali, C.Zietz, E. Ramazzotti, F. Ensoli, M. Andreoni, P. Pezzotti, G. Rezza, R. Yarchoan, R.C. Gallo, and B. Ensoli, Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's Sarcoma, Blood 93(12) (1999), pp. 4044–4058.
  • D.M. Muema, N.A. Akilimali, O.C. Ndumnego, S.S. Rasehlo, R. Durgiah, D.B.A. Ojwach, N. Ismail, M. Dong, A. Moodley, K.L. Dong, Z.M. Ndhlovu, J.M. Mabuka, B.D. Walker, J.K. Mann, and T.Ndung'u, Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection, BMC Med. 18 (2020).
  • F. Pak, A.R. Mwakigonja, P Kokhaei, N Hosseinzadeh, P. Pyakurel, E. Kaaya, G. Bogdanovic, G.Selivanova, and P. Biberfeld, Kaposi's Sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's Sarcoma lesions, Eur. J. Cancer 43 (2007), pp. 1877–1882.
  • A.S. Perelson and D.E. Kirschner, Dynamics of HIV infection of CD4 T cells, Math. Biosci. 114 (1993), pp. 81–125.
  • L.S. Pontryagin, V.G. Boltyanskii, R.V. Gamkrelidze, and E.F. Mishchenko, The Mathematical Theory of Optimal Processes, Wiley, New York, 1962.
  • G. Rappocciolo, M. Jais, P.A. Piazza, D.C. DeLucia, F.J. Jenkins, and C.R. Rinaldo, Human herpesvirus 8 infects and replicates in langerhans cells and interstitial dermal dendritic cells and impairs their function, J. Virol. 91(20) (2017).
  • R. Shibagaki, S. Kishimoto, and H. Takenaka, Recombinant interleukin 2 monotherapy for classic Kaposi Sarcoma, Arch Dermatol. 134(10) (1998), pp. 1193–1196.
  • A.K. Smith, Stimulation of Immune Response with Low Doses of Cytokines, Cornell Research Foundation Inc, New York, NY, 2003.
  • L. Sompayrac, How the Immune System Works, 6th ed., John Wiley & Sons, West Sussex, 2019.
  • B. Szomolay and E.M. Lungu, A mathematical model for the treatment of AIDS – related Kaposi's Sarcoma, J. Biol. Syst. 22(3) (2014), pp. 495–522.
  • P. van den Driessche and J. Watmough, Reproduction numbers and sub – threshold endemic equilibria for compartmental models of disease transmission, Math. Biosci. 180 (2002), pp. 29–48.
  • R. Yarchoan, J.M. Pluda, K.M. Wyvill, K. Aleman, I.R. Rodriguez-Chavez, G. Tosato, A.T. Catanzaro, S.M. Steinberg, and R.F. Little, Treatment of AIDS-related Kaposi's Sarcoma with interleukin-12: Rationale and preliminary evidence of clinical activity, Crit. Rev. Immunol. 27(5) (2007), pp. 401–414. HIV and AIDS Malignancy Branch.